AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 1 filers reported holding AKCEA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $334,000 | +32.0% | 18,386 | -0.4% | 0.00% | +100.0% |
| Q2 2020 | $253,000 | +29.1% | 18,457 | +35.0% | 0.00% | 0.0% |
| Q1 2020 | $196,000 | -47.5% | 13,676 | -37.9% | 0.00% | -50.0% |
| Q4 2019 | $373,000 | -8.8% | 22,012 | -17.2% | 0.00% | 0.0% |
| Q3 2019 | $409,000 | -38.8% | 26,600 | -6.7% | 0.00% | -50.0% |
| Q2 2019 | $668,000 | -25.8% | 28,507 | -10.3% | 0.00% | -20.0% |
| Q1 2019 | $900,000 | -5.6% | 31,768 | +0.5% | 0.01% | -28.6% |
| Q4 2018 | $953,000 | -25.5% | 31,603 | -13.5% | 0.01% | -22.2% |
| Q3 2018 | $1,279,000 | +43.2% | 36,517 | -3.0% | 0.01% | +50.0% |
| Q2 2018 | $893,000 | +6.6% | 37,651 | +15.1% | 0.01% | +20.0% |
| Q1 2018 | $838,000 | +26.8% | 32,725 | -14.1% | 0.01% | 0.0% |
| Q4 2017 | $661,000 | – | 38,076 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
| Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
| Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
| ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
| Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
| Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
| FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
| Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |